Jutta Huvila

P53abn Endometrial Cancer: Understanding the most aggressive endometrial cancers in the era of molecular classification (2021)

International Journal of Gynecological Cancer

Jamieson Amy, Thompson Emily F., Huvila Jutta, Gilks C. Blake, McAlpine Jessica N.

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis (2021)

Journal of Pathology

Huvila Jutta, Pors Jennifer, Thompson Emily F, Gilks C Blake

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and Proactive Molecular Risk Classifier for Endometrial Cancer classifier (2021)

Human Pathology

Huvila Jutta, Orte Katri, Vainio Paula, Mettälä Tuukka, Joutsiniemi Titta, Hietanen Sakari

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study (2020)

PLoS Medicine

Casper Reijnen, Evangelia Gogou, Nicole C. M. Visser, Hilde Engerud, Jordache Ramjith, Louis J. M. van der Putten, Koen van de Vijver, Maria Santacana, Peter Bronsert, Johan Bulten, Marc Hirschfeld, Eva Colas, Antonio Gil-Moreno, Armando Reques, Gemma Mancebo, Camilla Krakstad, Jone Trovik, Ingfrid S. Haldorsen, Jutta Huvila, Martin Koskas, Vit Weinberger, Marketa Bednarikova, Jitka Hausnerova, Anneke A. M. van der Wurff, Xavier Matias-Guiu, Frederic Amant, Leon F. A. G. Massuger, Marc P. L. M. Snijders, Heidi V. N. Küsters-Vandevelde, Peter J. F. Lucas, Johanna M. A. Pijnenborg

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Poor outcome in hypoxic endometrial carcinoma is related to vascular density (2019)

British Journal of Cancer

Reijnen C, van Weelden WJ, Arts MSJP, Peters JP, Rijken PF, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, Colas E, Gil-Moreno A, Reques A, Mancebo G, Krakstad C, Trovik J, Haldorsen IS, Huvila J, Koskas M, Weinberger V, Minar L, Jandakova E, Snijders MPLM, van den Berg-van Erp S, Kusters-Vandevelde HVN, Matias-Guiu X, Amant F, Massuger LFAG, Bussink J, Pijnenborg JMA

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study (2019)

Human Pathology

Nicole C.M. Visser, Louis J.M. van der Putten , Alexvan Egerschot, Koen K.Van de Vijver, , Peter Bronsert, Marc Hirschfeld, Eva Colas, Antonio Gil-Moreno, Angel Garcia, Gemma Mancebo, Francesc Alameda, Camilla Krakstad, Ingvild L.Tangen, JuttaHuvila, Stefanie Schrauwen, Martin Koskas, Francine Walker, Vit Weinberger, Lubos Minar, Jitka Hausnerova, Marc P.L.M. Snijders, Saskiavan den Berg-van Erp, Xavier Matias-Guiu, Jone Trovik, Frédéric Amant, Leon F.A.G. Massuger, Johan Bulten, Johanna M.A. Pijnenborg

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study (2018)

International Journal of Gynecological Cancer

van der Putten LJM, Visser NCM, van de Vijver K, Santacana M, Bronsert P, Bulten J, Hirschfeld M, Colas E, Gil-Moreno A, Garcia A, Mancebo G, Alameda F, Trovik J, Kopperud RK, Huvila J, Schrauwen S, Koskas M, Walker F, Weinberger V, Minar L, Jandakova E, Snijders MPLM, van den Berg-van Erp S, Matias-Guiu X, Salvesen HB, Werner HMJ, Amant F, Massuger LFAG, Pijnenborg JMA, Pijnenborg JMA

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Endometriumkarsinooman molekulaarinen luokittelu ja kudosperäiset ennustetekijät (2018)

Duodecim

Huvila J, Carpén O

(Artikkeli ammattilehdessä tai kirjoitus ammatillisessa blogissa (D1))

Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma (2018)

Gynecologic Oncology

Huvila J, Laajala TD, Edqvist PH, Mardinoglu A, Talve L, Ponten F, Grenman S, Carpen O, Aittokallio T, Auranen A

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways (2018)

International Journal of Cancer

Cuppens T, Moisse M, Depreeuw J, Annibali D, Colas E, Gil-Moreno A, Huvila J, Carpen O, Zikan M, Matias-Guiu X, Moerman P, Croce S, Lambrechts D, Amant F

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Publications

Sort by:

P53abn Endometrial Cancer: Understanding the most aggressive endometrial cancers in the era of molecular classification (2021)

Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis (2021)

Molecular subtype diagnosis of endometrial carcinoma: comparison of the next-generation sequencing panel and Proactive Molecular Risk Classifier for Endometrial Cancer classifier (2021)

Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study (2020)

Poor outcome in hypoxic endometrial carcinoma is related to vascular density (2019)

Addition of IMP3 to L1CAM for discrimination between low- and high-grade endometrial carcinomas: a European Network for Individualised Treatment of Endometrial Cancer collaboration study (2019)

Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study (2018)

Endometriumkarsinooman molekulaarinen luokittelu ja kudosperäiset ennustetekijät (2018)

Combined ASRGL1 and p53 immunohistochemistry as an independent predictor of survival in endometrioid endometrial carcinoma (2018)

Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways (2018)